Select Page

City Wound Care Center

We are proud to feature the Sanuwave dermaPACE® device. This ground-breaking device to assist wound healing is currently only available to physicians and patients involved in a U.S. Invstigation Device Exemption clinical trial.

 

City Wound Care Center

We invite you to read more about dermaPACE® and contact us to see if you are a candidate to participate in our clinical trial. Currently, in the USA dermaPACE® is only indicated for the treatment of diabetic foot ulcers.

City Wound Care Center

Led by Dr. Lawrence Silverberg, the doctors and staff at City Footcare are currently participating in the Sanuwave dermaPACE® clinical trial.